After the publication of the Review by Simon Lo et al., Role of stereotactic radiosurgery and fractionated stereotactic radiotherapy in pediatric brain tumors, published in the January 2008 issue of Expert Review of Neurotherapeutics (Expert Rev. Neurotherapeutics 8[1], 121–132 [2007]), it has been brought to our attention that the following statement is incorrect:
Stafford and colleagues from Mayo Clinic reported the treatment results of 12 patients with 17 tumors, including both adults and children, who underwent gamma knife-based SRS for recurrent ependymoma [11]. The median prescribed dose was 15 Gy.
The correct statement is given below:
Stafford and colleagues from Mayo Clinic reported the treatment results of 12 patients with 17 tumors, including both adults and children, who underwent gamma knife-based SRS for recurrent ependymoma [11]. The median prescribed dose was 18 Gy.
The editors of Expert Review of Neurotherapeutics and the authors would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.